🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
This study will test the effectiveness and safety of treatment with MK-0893...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00631488
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
This study is being carried out to see if dapagliflozin in addition to metf...
Status
Completed
Location
Research Site
Start Date
2009-02
Trial ID
NCT00855166
Treatments Being Tested
The purpose of this study is to evaluate the effect of TAK-875 (fasiglifam)...
Status
Terminated
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01829464
Study will evaluate if a combination of saxagliptin and dapagliflozin added...
Status
Completed
Location
Research Site
Start Date
2014-09-09
Trial ID
NCT02284893
This two-phase study was to examine if 16 weeks of treatment with sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-24
Trial ID
NCT01477853
The purpose of this study is to evaluate the efficacy of fasiglifam (TAK-87...
Status
Terminated
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01834274
Treatments Being Tested
This study will evaluate the efficacy and safety of 100 mg DRBP108 tablets ...
Status
Completed
Location
Peking University First Hospital
Start Date
2020-01-02
Trial ID
NCT04161430
The purpose of this study is to test the safety and effectiveness of sitagl...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00541775
Treatments Being Tested